Delivery Order SPE2DB25D2203-SPE2DB25FPSFH
- Not listed
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a $13,493.92 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside basis through competitive procurement, reflecting AmerisourceBergen's established capability to fulfill federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $17,573.28 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, issued under a firm fixed-price delivery order contract, represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.28 for Zepbound 2.5 mg/0.5 mL pen injections, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under a larger vehicle within the federal pharmaceutical supply chain supporting military and defense healthcare needs....
- The Defense Logistics Agency awarded a $16,313.49 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $13,398.50 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $5,735.65 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen in 0.5 mL units, with a ceiling value of $2,344.20. The contract, awarded on July 31, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award carries no set-aside designation, indicating it...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSFHDelivery Order
The Defense Logistics Agency awarded a $13,402.26 delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen (0.5 mL) with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, specifically supporting the military and veteran healthcare systems managed through the Defense Logistics Agency's medical supply chain. This delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated its capability to meet federal procurement requirements through open competition and maintains significant capacity to fulfill the Defense Health Agency's ongoing medication and medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 8/22/25 |